Related Experiment Video
Updated: Jul 18, 2026
05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Diet, obesity and diabetes: a current update
Celia G Walker1, M Gulrez Zariwala, Mark J Holness
1Centre for Diabetes and Metabolic Medicine, Institute of Cell and Molecular Science, St Bartholomew's and the Royal London School of Medicine and Dentistry, Queen Mary's Hospital, University of London, UK.
Clinical Science (London, England : 1979)
|December 13, 2006
Summary
Obesity and Type 2 diabetes are linked to complex energy balance regulation, particularly impaired adipose tissue function. Understanding these links can improve prevention and treatment strategies for metabolic disorders.
Area of Science:
- Metabolic regulation and obesity research
Background:
- Rising global obesity rates highlight complex energy balance regulation beyond simple calorie imbalance.
- Adipose (fat) tissue and its secreted adipokines are crucial for energy homeostasis.
- Obesity impairs adipose tissue function, contributing to insulin resistance and Type 2 diabetes.
Purpose of the Study:
- To review how adipose tissue regulates energy intake and expenditure.
- To analyze the impact of dietary macronutrients on obesity and Type 2 diabetes susceptibility.
- To explore how abnormal adipose function exacerbates metabolic disorders.
Main Methods:
- Literature review of adipose-tissue factors in energy balance control.
- Analysis of dietary macronutrient composition's role in metabolic health.
- Examination of the interplay between obesity, insulin resistance, and adipose function.
Main Results:
- Energy balance is intricately regulated by adipose tissue, influenced by factors beyond simple energy intake versus expenditure.
- Dietary macronutrients significantly affect susceptibility to obesity and Type 2 diabetes.
- Impaired adipose tissue function in obesity exacerbates insulin resistance and Type 2 diabetes.
Conclusions:
- A deeper understanding of energy balance control in normal, obese, and diabetic states is essential.
- This knowledge can lead to more effective practical approaches for preventing and treating obesity and metabolic disorders.
- Targeting adipose tissue function presents a potential avenue for therapeutic intervention.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...